Login
$QCLS
$0.46 -$0.01 (2.33%) Close

Ownership

13F as of Q2 2026 · 8.2M shares outstanding

Who owns QCLS?

By type of holder
Institutions 9.0% Insiders 6.3% Everyone else 84.7%
Concentration Top 10 holders own 116.6%
PharmaCyte Biotech, Inc. 103.5% · Voss Chelsea Sierra 3.7%
Institutional ownership
9.0%
+1.3 pts vs last qtr
Institutional holders
21
+3 vs last qtr
Net shares bought
+109.2K
by institutions in Q2 2026
New / sold out
6 / 3
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Vanguard Capital Management LLC +77.5K
  • Balyasny Asset Management L.P. NEW +57.7K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Quinn Opportunity Partners LLC −88.4K
  • Jane Street Group, LLC −38.9K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Q/C Technologies Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025
+6784.3%
+6784.26% a year
Each share's claim on the business
−98.5%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $3.23M
over 2 fiscal years
Diluted shares, split-adjusted
24.4K885.8K1.7M2024: 25.1K shares'242025: 1.7M shares'25
Buybacks Stock-based comp
$0$1.1M$2.2M2024 buybacks: $02024 stock comp: $1.1M'242025 buybacks: $02025 stock comp: $2.2M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%
Quarterly turnover
32.4%
of institutional shares changed hands
Top 10 managers, median time held
2 quarters

Super Investors

Investment managers reporting QCLS on Form 13F
QO
Quinn Opportunity Partners LLC
Shares
123.0K
% of company
1.50%
Change vs last qtr
−88.4K (−41.8%)
Held since
Q4 '25
JS
Jane Street Group, LLC
Shares
87.2K
% of company
1.07%
Change vs last qtr
−38.9K (−30.9%)
Held since
Q4 '25

22 more super investors behind a free account

See every manager holding Q/C Technologies Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting QCLS on Form N-PORT; together they hold 2.6% of the company
VE
Position value
$449K
% of company
1.40%
% of the fund
0.00%
As of
June 30, 2026
FE
Fidelity Concord Street Trust
Position value
$116K
% of company
0.61%
% of the fund
0.00%
As of
August 31, 2026

8 more funds behind a free account

See every fund holding Q/C Technologies Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
PB
PharmaCyte Biotech, Inc.
5%+ holder13D · 74.0%
Shares
8.5M
% of company
103.49%
Change vs last qtr
—
Held since
—
VC
Voss Chelsea Sierra
Insider
Shares
301.5K
% of company
3.68%
Change vs last qtr
—
Held since
—

6 more holders behind a free account

See every insider and 5%+ holder of Q/C Technologies Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support